로딩 중…
지수 로딩 중…
Ahn-Gook Pharmaceutical Co., Ltd.
001540· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩10,200-4.67%
2026-06-19
Price Chart
Ahn-Gook Pharmaceutical Co., Ltd.+29.11%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 133.03B KRW |
| Revenue | 330.05B KRW |
| Net Income | -2.58B KRW |
| Total Assets | 326.16B KRW |
| Net Assets | 170.81B KRW |
| Employees | 420 |
| Value | |
| P/B | 0.78x |
| P/S | 0.40x |
| EV/EBITDA | 36.45x |
| FCF Yield | 27.98% |
| Profitability | |
| ROE | -1.51% |
| ROA | -0.79% |
| Op. Margin | 1.30% |
| Revenue Growth | 30.59% |
| Earnings Growth | 245.71% |
| Financial Health | |
| Debt Ratio | 190.95% |
| Total Debt | 72.48B KRW |
| FCF | 37.22B KRW |
| Cash | 49.56B KRW |
| Current Ratio | 1.62x |
| Net Debt/EBITDA | 5.36x |
| Dividend | |
| Div. Yield | 5.92% |
| Div. Growth | 43.86% |
| Performance | |
| 1Y Return | 29.11% |
| 1M Return | -8.19% |
| From 52W High | -19.87% |
| 1Y MDD | -22.55% |
| Trading | |
| Volume | 171,727 shares |
| Foreign Own. | 3.18% |
| Per Share | |
| EPS | 1,247 KRW |
| BPS | 14,946 KRW |
Company Info
Anguk Pharmaceutical, established in 1959, manufactures and sells pharmaceuticals and health functional foods, having been listed on the KOSDAQ market in 2000. It holds several competitive drugs, including Cinechura, Revotension, Revosartan, and Fevarojet, specializing in antitussive expectorant and circulatory system medications. Its Hanam-eup, Hwaseong-si plant, certified by GMP, ensures the production of high-quality pharmaceuticals and engages in contract manufacturing organization (CMO) to maintain stable supply. Anguk Pharmaceutical is headquartered in Gwacheon-si, Gyeonggi-do.